Opus Point Partners Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $242K | Buy |
3,892
+508
| +15% | +$31.6K | 0.44% | 48 |
|
|
2019
Q2 | $241K | Buy |
3,384
+587
| +21% | +$41.8K | 0.36% | 59 |
|
|
2019
Q1 | $219K | Buy |
+2,797
| New | +$219K | 0.3% | 71 |
|
|
2017
Q4 | – | Sell |
-2,435
| Closed | -$207K | – | 61 |
|
|
2017
Q3 | $207K | Sell |
2,435
-952
| -28% | -$80.9K | 0.19% | 56 |
|
|
2017
Q2 | $257K | Sell |
3,387
-2,575
| -43% | -$195K | 0.24% | 49 |
|
|
2017
Q1 | $394K | Buy |
5,962
+1,812
| +44% | +$120K | 0.29% | 48 |
|
|
2016
Q4 | $263K | Buy |
+4,150
| New | +$263K | 0.21% | 42 |
|